InsidersTradesSigma
Aclarion, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Track the Aclarion, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Technology sector, Aclarion, Inc. has recorded 22 insider filings. Market capitalisation: €1,101.8bn. The latest transaction was disclosed on 12 June 2026 (Attribution). Among the most active insiders: Neal David K. The full history is accessible without an account.
22
Insider Decl.
0
Thresholds
€263,390
9 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Aclarion, Inc. Strong Buy (bullish), based on 42 analysts. Average price target: US$1,486.00.
58Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,819 of 25,821 companies
52.2
score / 100
Value26
Quality79
FCF yld0.2%
Earn yld0.8%
EV/EBITDA58.2x
ROE67%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 June 2026
Declarations22 total
20,000 sharesCommon StockSEC:0001683168-26-004806:0
100,000 sharesCommon StockSEC:0001683168-26-004807:0
20,000 sharesCommon StockSEC:0001683168-26-004809:0
20,000 sharesCommon StockSEC:0001683168-26-004810:0
100,000 sharesCommon StockSEC:0001683168-26-004811:0
20,000 sharesCommon StockSEC:0001683168-26-004812:0
20,000 sharesCommon StockSEC:0001683168-26-004814:0
50,000 sharesCommon StockSEC:0001683168-26-004813:0
5,664 shares@ US$3.180.0000% mcap100.0% of flowCommon StockSEC:0001683168-26-003744:0
Ideal exit: 6 Feb 2027 (T+270)
2,500 shares@ US$3.100.0000% mcap4.5% of flowCommon StockSEC:0001683168-26-003694:0
Ideal exit: 5 Feb 2027 (T+270)
1 shares@ US$1,000.0049.7% of flowSeries A Preferred StockSEC:0001683168-23-001855:0
1 shares@ US$1,000.0050.3% of flowSeries A Preferred StockSEC:0001683168-23-001067:0
Ideal exit: 13 Nov 2023 (T+270)
4,100 shares@ US$0.43100.0% of flowCommon StockSEC:0001683168-22-008686:0
Ideal exit: 25 Sept 2023 (T+270)
2,289 shares@ US$0.4218.4% of flowCommon StockSEC:0001683168-22-008688:0
Ideal exit: 24 Sept 2023 (T+270)
152,128 shares0Common StockSEC:0001683168-22-008267:0
1,091,894 shares0Common StockSEC:0001683168-22-008227:0
152,128 shares0Common StockSEC:0001683168-22-008226:0
34,400 shares@ US$4.350.0000% mcap100.0% of flowCommon StockSEC:0001683168-22-002906:0
Ideal exit: 16 Jan 2023 (T+270)
11,000 shares@ US$4.350.0000% mcap100.0% of flowCommon StockSEC:0001683168-22-002909:0
Ideal exit: 16 Jan 2023 (T+270)
1,000 shares@ US$4.350.0000% mcap100.0% of flowCommon StockSEC:0001683168-22-002907:0
Ideal exit: 16 Jan 2023 (T+270)
22 of 22 declarations
About Aclarion, Inc.
Aclarion, Inc. is a technology company focused on developing health solutions based on artificial intelligence. It aims to improve clinical outcomes through advanced analytics.